| General Information of Drug Metabolite (DM) (ID: DM019806) |
| DM Name |
PT2385 M8
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
UDP-glucuronosyltransferase 1A6 (UGT1A6)
|
DME0072
|
| Conjugation - Glucuronide conjugation |
PT2385
|
[1] |
|
UDP-glucuronosyltransferase 2B15 (UGT2B15)
|
DME0049
|
| Conjugation - Glucuronide conjugation |
PT2385
|
[1] |
|
UDP-glucuronosyltransferase 2B17 (UGT2B17)
|
DME0066
|
| Conjugation - Glucuronide conjugation |
PT2385
|
[1] |
|
UDP-glucuronosyltransferase 2B7 (UGT2B7)
|
DME0040
|
| Conjugation - Glucuronide conjugation |
PT2385
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| PT2385 |
DR3296
|
Phase 2 |
Von hippel-lindau disease |
|
|
| References |
| 1 |
Metabolic Profiling of the Novel Hypoxia-Inducible Factor 2 Inhibitor PT2385 In Vivo and In Vitro
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
